KeyBanc reduces its price target on Hinge Health, Inc. (HNGE) to $55 and maintains an overweight rating
I'm PortAI, I can summarize articles.
KeyBanc has reduced its price target on Hinge Health, Inc. (NYSE:HNGE) to $55 from $70 while maintaining an Overweight rating. This adjustment comes as Hinge Health is listed among the 11 Newly-Listed NYSE Stocks to Buy Now. Additionally, Evercore ISI analyst Elizabeth Anderson has lowered the price target to $50 from $65.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments